Discure Technologies

Reversing Degenerative Disc Disease

Health Tech & Life Sciences

Active

Series A Herzliya Founded 2021

Website ↗ LinkedIn

Total raised

$21.0M

Last: Series A 2024-09

Stage

Series A

Founded

2021

Headcount

Herzliya

Sector

Health Tech & Life Sciences

About

Discure Technologies developed a minimally invasive device to treat and reverse degenerative disc disease, reducing pain and restoring functionality to the patient. The system is designed to eliminate the need for invasive surgery and reduce the use of opioids.

Funding history · 3 rounds · $21.0M total

2024-09

Series A $11.0M

2024-09

SAFE $5.0M

2022-03

Seed $5.0M

Sectors & technology

Primary sector

Health Tech & Life Sciences

Sub-sectors

Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics

Technologies

Materials & SubstancesImplants

Target customers

Healthcare & Life SciencesHealthcarePatientsProviders

Business model

B2C

Highlights

1 PatentsVerified

Name	Discure Technologies
Slug	discure-technologies
Type	Israeli Startup
Founded	2021
HQ city	Herzliya
HQ country	IL
Primary sector	[object Object]
Sectors	[object Object], [object Object], [object Object]
Business models	B2C
Target customers	[object Object], [object Object], [object Object], [object Object]
Status	active
Current stage	Series A
Public stage	A
Total raised (USD)	21,000,000
Last round	Series A (2024-09)
Website	https://discuremd.com
Israeli Companies Registrar	516554326

Date	Round	Amount	Lead investors	All investors
2022-03	Seed	$5,000,000	Rainbow Medical	Rainbow Medical, Johnson & Johnson Innovation, Katao Venture Partners, KYTO
2024-09	SAFE	$5,000,000		Sanara Capital, Bold Capital Partners, Supernova Invest
2024-09	Series A	$11,000,000	Bold Capital Partners	Bold Capital Partners, Supernova Invest, Sanara Capital

Name	Role	LinkedIn
Hassan Serhan
Yuval Mandelbaum
Yossi Gross
Shirley Giorini
Yehuda Zadok

Discure Technologies

About

Funding history · 3 rounds · $21.0M total

Sectors & technology

Highlights

Tags